CMA closes probe into three Concordia drugs
The UK’s competition enforcer has shuttered part of its antitrust probe of drugmaker Concordia after deciding it did not have the need or resources to continue investigating three of the company’s drugs.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.